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Abstract
Objectives
In Western contexts nut consumption is associated with better health. We examined the
associations of nut consumption with cardiovascular disease risk in the non-Western setting
of Southern China.
Methods
In the Guangzhou Biobank Cohort Study we used multivariable linear regression to exam-
ine the associations of baseline nut (mainly peanuts) consumption (none (n = 6688), <3 por-
tions/week (n = 2596) and3 portions/week (n = 2444)) with follow-up assessment of
Framingham cardiovascular disease score (excluding smoking) and its components in
older Chinese (50 years) (follow-up 57.8%).
Results
Nut consumption was not associated with Framingham score (3 portions/week compared
to none: 0.02 95% confidence interval (CI) -0.11 to 0.15), systolic blood pressure (-0.66
mmHg 95% CI -1.94, 0.62), diastolic blood pressure (-0.69 mmHg 95% CI -1.44, 0.07),
HDL-cholesterol (-0.01 mmol/L 95% CI -0.02, 0.005), LDL-cholesterol (-0.01 mmol/L 95%
CI -0.05, 0.02) or fasting glucose (0.04 mmol/L 95% CI -0.02, 0.09), adjusted for baseline
values, energy intake, age, sex, phase of recruitment, socio-economic position, lifestyle
and baseline health status.
Conclusions
Observations concerning the benefits of nut consumption may be contextually specific, per-
haps depending on the type of nut consumed.
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Introduction
Nuts are promoted as part of a healthy diet [1]. Observational studies in Western settings have
shown that nut consumption is negatively associated with cardiovascular disease (CVD), dia-
betes and mortality [2–5]. Long-term randomized controlled trials (RCTs) have shown that the
Mediterranean diet, which is rich in nuts, reduces CVD or its risk factors [6, 7]. Some short-
term RCTs also showed some protective effects of nut consumption on cardiovascular health,
such as lower total and LDL-cholesterol and better glycemic control [8–10]. However, these
dietary RCTs are difficult to interpret, because some of the interventions changed more than
nut consumption and the type of nuts consumed varied [11]. Moreover, lack of compliance
may bias RCTs towards the null.
Nuts are rich in unsaturated fatty acids, minerals (e.g., magnesium and potassium), fibers,
plant proteins, and antioxidant vitamins (e.g., vitamin E) [12–14], although the benefits of
unsaturated fats and vitamin E have been questioned [15, 16]. The observed associations of nut
consumption with cardiovascular health could be the result of beneficial effects of nutrients in
nuts, however, it could also be due to residual confounding by socio-economic position (SEP)
or other life style factors [17, 18]. Reverse causation is also possible as people might eat more
nuts in response to poor health. Evidence from non-western settings with a potentially differ-
ent confounding structure and diet may help identify whether these observed associations are
biologically based or contextually specific results of unmeasured confounding.
To our knowledge no previous study has examined the associations of nut consumption
with cardiovascular risk in China. We examined the prospective associations of nut consump-
tion with Framingham score and CVD risk factors in a large study of older adults (50+ years)
from the economically developing non-western setting of Guangzhou in Southern China, and
whether the associations varied by health status. We also examined whether the associations
varied by sex and among men by smoking status.
Materials and Methods
Ethics statement
The Guangzhou Medical Ethics Committee of the Chinese Medical Association approved the
study and all participants gave written, informed consent before participation.
Participants
The baseline examination of Guangzhou Biobank Cohort Study (GBCS) was conducted from
2003 to 2008, and the follow-up from 2008 to 2012. Details of GBCS have been reported previ-
ously [19]. Briefly, GBCS is a 3-way collaboration between Guangzhou Number 12 Hospital
and the Universities of Hong Kong and Birmingham, UK. Recruitment of participants was
from “The Guangzhou Health and Happiness Association for the Respectable Elders”
(GHHARE), a community social and welfare organization. GHHARE unofficially aligned with
the municipal government. Membership is open to Guangzhou permanent residents aged 50
years or above for a nominal fee of 4 CNY (50 US cents) per month. GHHARE included
about 7% of Guangzhou residents in this age group, with branches in all 10 districts of Guang-
zhou, the capital city of Guangdong province in southern China. Within sex and age group, the
GBCS participants had fairly similar prevalence of chronic diseases, such as diabetes and
hypertension, as a nationally representative sample of urban Chinese [19]. The baseline and
follow-up examination included an interview concerning lifestyle, family and personal medical
history and assessment of weight, height, waist circumference, blood pressure, fasting plasma
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glucose, lipids and inflammatory markers. Plasma glucose and lipids were measured by Roche
COBAS automatic biochemical analyzer.
Nut consumption
Nut consumption was considered as 25 gram portions per week, obtained from a validated
food frequency questionnaire (FFQ) used in phases 1 and 2, but not in phase 3 [19, 20]. The
FFQ contained 300 food items, including 5 commonly eaten nuts from Southern China (chest-
nut, cashew, peanut, walnut and almonds). The participants were asked the usual amount and
frequency of each nut consumed in the past week, with a usual serving size specified. Nut con-
sumption was reported as portions per week and categorized into never,<3 portions/week and
3 portions/week, based on the frequency of consumption and the usual amount per occasion.
The most commonly eaten nut was peanuts, consumed by 36% of the participants. For other
types of nut, 10% of participants ever consumed walnuts, 5% ever consumed chestnuts, 2%
ever consumed almonds and1% ever consumed cashew nuts.
Outcomes
The primary outcome was the Framingham score from follow up stage [21] which predicts cor-
onary heart disease (CHD) risk from sex, age, LDL-cholesterol, HDL-cholesterol, blood pres-
sure, smoking and history of diabetes. We removed smoking from the score, so that it was not
included, so as to examine the potential biological effect on these risk factors. A higher score
predicts higher CHD risk, consistent with the updated risk assessment equations for athero-
sclerotic CVD in the 2013 American College of Cardiology and the American Heart Associa-
tion guidelines [22]. The Framingham score over-estimates CVD risk in Chinese populations,
but ranks correctly [23]. The secondary outcomes were components of the Framingham score.
Health status
We constructed a 9-item index to assess health status, similar to one previously used, which
was strongly associated with mortality [24], by counting chronic conditions (self-reported
heart disease, stroke, diabetes, chronic obstructive pulmonary disease (COPD) and/or asthma,
and hypertension), use of health services (regular use of medication and any hospital admission
in the last 6 months), cognitive impairment (delayed recall score of 3 or less out of 10), and
weight loss of more than 2.5 kg in the last 12 months.
Statistical analysis
Multivariable linear regression was used to assess the adjusted associations of nut consumption
with Framingham score, while multivariable censored linear regression was used to assess asso-
ciations with blood pressure, lipids and fasting glucose, because people taking medications for
hypertension (n = 3871), hyperlipidemia (n = 790) or diabetes (n = 1263) might result in lower
blood pressure, LDL-cholesterol and fasting glucose than the true measure and higher HDL-
cholesterol. These models censored the outcomes for those on medication at the observed
value so that the true measurement for blood pressure, LDL-cholesterol and fasting glucose
was assumed to be that observed or higher, while for HDL-cholesterol it was assumed to be
that observed or lower. We included potential confounders sequentially. Model 1 adjusted for
sex, age (in 5-year age groups), recruitment phase, baseline values of the same risk factor and
total energy intake which was calculated from the food frequency questionnaire and dietary
composition tables based on McCance and Widdowson [25] and the Chinese Medical Sciences
Institute [26]. Model 2 additionally adjusted for life course SEP (father’s occupation, education,
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longest-held occupation and household income per head) and lifestyle (smoking, alcohol use
and physical activity). Model 3 additionally adjusted for health status. Model 4 additionally
adjusted for body mass index (BMI) and waist-hip ratio (WHR), considering the unclear role
of nut consumption in adiposity.
To assess reverse causality, we examined whether these associations varied by health status,
because people in poor health consuming more nuts as a protective measure would generate
different associations of nut consumption with CVD risk factors by health status. We assessed
differences by health status from the heterogeneity across subgroups and the p-values of the
relevant interaction terms in models including interactions with other confounders to avoid
confounding by these other interactions. We also similarly examined whether the associations
varied by sex, and among men by smoking status.
Information on exposures and potential confounders was missing for less than 5% apart
from the longest-held occupation (14.21%) and father’s occupation (42.62%). Missing expo-
sures and potential confounders were predicted based on a flexible additive regression model
with predictive mean matching incorporating all exposures, potential confounders and out-
comes. We imputed values 10 times and results from the 10 imputations were summarized
into single estimated beta-coefficients with confidence intervals and p-values adjusted for the
missing data uncertainty [27].
Sensitivity analysis
Given we previously found SEP was not clearly associated with CVD risk factors among men
[28], we did a separate analysis for men, where confounding by socioeconomic factors might
be less relevant.
Results
Of the original 20,305 participants in phases 1 (10389) and 2 (9916) of GBCS, till follow-up
18,569 were still alive, 1446 died and 290 had a status of unknown. Of the 18,569 alive and able
to participate in the follow-up, 11,741 participated (63% response), and 11,728 had complete
data on nut consumption and energy intake. Compared with those who did not participate in
the follow-up, participants in the follow-up were younger, with higher education, a non-man-
ual occupation (of self and father), less likely to be smokers or alcohol users, more physically
active, had lower BMI and WHR, and were in better health.
There were more women (8399) than men (3329), and the women were younger (mean age
61.2 (standard deviation (SD) 6.4) than the men (mean age 64.2 (SD 6.2)). Their age ranged
from 50 to 95 years, with only 207 participants older than 75 years. Nut consumption (25 gram
portions per week) ranged from 0.0 to 70.0, and the median was 0.0 (mean consumption 1.6
(SD 3.0)), with 94% of participants eating less than 7 portions per week.
Greater nut consumption was associated with higher socio-economic position (education,
non-manual occupation (of self and father) and higher personal income) for men and women
(Table 1). Nut consumption had inconsistent associations with lifestyle and attributes of health,
being positively associated with alcohol use, physical activity, and BMI, but was not associated
with age, smoking status, WHR or health status.
Prospectively nut consumption was unrelated to Framingham score and its biological com-
ponents (systolic blood pressure, diastolic blood, HDL-cholesterol, LDL-cholesterol and fasting
glucose) (Table 2). These associations did not vary by health status or sex (p-values0.12).
Correspondingly, nut consumption was unrelated to Framingham score and its biological com-
ponents among men only (Table 3), and these associations did not vary by health status or
smoking status (p-values0.07).
Nut Consumption and Cardiovascular Risk
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Table 1. Characteristics by Nut Consumption in Older Chinese (3329men and 8399 women) in Phases 1 and 2 of the Guangzhou Biobank Cohort
Study. Abbreviations: IPAQ, International Physical Activity Questionnaire; HEPA, health-enhancing physical activity, i.e., vigorous activity at least 3 days a
week that corresponds to a minimum of 1500 metabolic equivalent (MET) minutes per week, or activity 7 days of the week that corresponds to at least 3000
METminutes per week.
Nut consumption (25g portions/week)
Men Women
0 <3 3 aP value 0 <3 3 aP value
N 1956 653 725 4738 1945 1724
Age group (%)
50–54 6.8 6.6 7.2 17.0 20.9 18.3
55–59 20.1 22.5 18.1 28.3 32.3 30.9
60–64 26.4 25.9 27.7 22.3 20.4 21.9
65–69 27.4 25.1 28.4 21.4 16.9 19.8
70–74 17.2 16.7 15.2 9.3 8.5 7.78
75–79 1.6 2.8 3.0 1.5 0.8 1.2
80 0.5 0.5 0.4 0.37 0.2 0.1 0.1 <0.001
Education (%)
Less than primary school 2.7 1.7 1.7 12.8 9.5 8.2
Primary school 29.7 23.4 19.5 38.8 33.2 35.3
Junior middle school 28.2 28.8 32.9 25.2 26.3 30.7
Senior middle school 24.1 25.0 24.6 18.0 23.7 19.2
Junior college 8.6 10.7 12.0 3.5 5.0 4.4
College or above 6.8 10.4 9.4 <0.001 1.8 2.4 2.2 <0.001
Father’s occupation (%)
Manual 81.2 81.0 74.3 79.1 76.7 74.6
Non-manual 18.8 19.0 25.7 0.01 20.9 23.3 25.4 0.01
Job type (%)
Manual 57.4 47.8 46.2 78.2 73.8 71.4
Non-manual 42.6 52.0 53.8 <0.001 21.8 26.2 28.6 <0.001
Income group (%)
< 10000 yuan 24.3 20.7 18.8 47.7 38.3 38.6
10000 to 15000 yuan 44.7 46.1 45.6 41.8 49.7 49.4
 15000 yuan 31.0 33.2 35.6 0.02 10.5 12.0 12.0 <0.001
Smoking status (%)
Never 41.3 48.7 43.3 96.6 97.1 97.0
Ex-smoker 28.6 25.0 30.2 1.8 1.0 1.4
Current smoker 30.1 26.3 26.5 0.01 1.6 1.9 1.6 0.12
Alcohol use (%)
Never 64.1 56.9 53.9 91.1 87.8 85.6
<1/month 12.6 22.2 17.4 5.3 8.1 8.5
<1/week 4.3 5.4 6.9 1.1 1.5 1.8
1-4/week 7.8 5.8 9.2 0.9 1.2 1.4
>5/week 8.6 7.9 10.9 1.2 0.8 1.9
Ex-drinker 2.7 1.7 1.7 <0.001 0.3 0.6 0.8 <0.001
Physical activity (IPAQ) (%)
Inactive 10.1 9.2 5.7 9.9 6.4 4.9
Minimally active 46.5 44.9 50.2 45.0 48.6 46.0
HEPA 43.4 45.9 44.1 0.01 45.0 45.0 49.1 <0.001
Body mass index 23.4 23.5 23.8 0.02 23.8 23.9 24.0 0.04
(Continued)
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Discussion
This large prospective study from an under-studied non-western developing population
showed no association of nut consumption, mainly peanuts, with Framingham score or its
components. The results did not vary by baseline health status or sex, indicating these results
were likely not due to changes in response to poor health.
Our results were inconsistent with 6 recent meta-analyses of observational studies from
Western countries including prospective studies where nut consumption was found to be asso-
ciated with lower cardiovascular risk including fewer CVD events and deaths [2–5, 29, 30], and
2 recent meta-analyses of RCTs where nut consumption reduced LDL-cholesterol and glucose
[10, 31]. However, our study is consistent with the same meta-analyses of RCTs where nut con-
sumption had no effect on HDL-cholesterol [10, 31], and an RCT where nut consumption was
not associated with the risk of myocardial infarction [32]. Some dietary interventions included
dietary changes involving more than increased nut consumption and used different types of
nuts, which make these dietary RCTs difficult to interpret.
Several explanations for our findings are plausible. Observational studies are vulnerable to
residual confounding by SEP, lifestyle and other dietary items. Observational studies in a differ-
ent population, with justifiable adjustment for confounders, may help verify causality. In
China, as in western studies, greater nut consumption was associated with higher SEP and
some aspects of a healthier lifestyle [17, 18]. However, our observation that overall nut con-
sumption was not associated with Framingham score or its components is inconsistent with
most studies including observational studies from western countries, where nut consumption
is usually associated with lower risk of developing CVD. Moreover, in our population for men
where there might be less confounding by SEP [28], nut consumption was also not associated
with CHD risk factors, indicating confounding by SEP is less likely in our study. Thus differ-
ences between the results from our study and western studies may have arisen because our
observations are less confounded.
Another possibility is reverse causation, if people in poor health might eat more nuts. In
some observational studies in Western countries, the negative associations of nut consumption
with CVD risk was attenuated after adjusting for health status suggesting that the observed
associations could partially be due to reverse causality [33, 34]. Here we specifically took
advantage of our large study to assess reverse causality by examining if associations differed by
health status. However, in our study the associations of nut consumption with Framingham
score and its components did not vary by health status, indicating reverse causation is unlikely.
Table 1. (Continued)
Nut consumption (25g portions/week)
Men Women
0 <3 3 aP value 0 <3 3 aP value
N 1956 653 725 4738 1945 1724
Waist hip ratio 0.898 0.900 0.899 0.74 0.855 0.847 0.851 0.01
Health status
Good health 35.0 36.0 31.7 36.1 37.2 36.4
Poor health 65.0 64.0 68.3 0.19 63.9 62.8 63.6 0.69
aP value from chi-square test for categorical variables and from one-way analysis of variants (ANOVA) for continuous variables, 2 sided; bold values
indicate P<0.05.
doi:10.1371/journal.pone.0137178.t001
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Table 2. Adjusted Associations of Nut Consumption with FraminghamRisk Score and CVDRisk Factors after Multiple Imputation in Older Chinese
in Phases 1 and 2 of the Guangzhou Biobank Cohort Study.
bModel n Nut consumption (25g portions/week) P-value
for
trend
P-value for
interaction by
sex
P-value for
interaction by
health status0
(n = 6688)
<3 (n = 2596) 3 (n = 2444)
ccoefﬁcient 95% CI coefﬁcient 95% CI
aFramingham Risk
Score
1 11495 reference 0.10 -0.02,
0.23
-0.002 -0.13,
0.13
0.44 0.14 0.23
2 11495 reference 0.13 0.01,
0.26
0.02 -0.11,
0.15
3 11495 reference 0.13 0.01,
0.26
0.02 -0.11,
0.15
4 11495 reference 0.14 0.02,
0.26
0.01 -0.12,
0.13
Systolic blood
pressure (mm Hg)
1 11592 reference -0.59 -1.81,
0.63
-0.62 -1.89,
0.65
0.26 0.69 0.34
2 11592 reference -0.64 -1.87,
0.60
-0.64 -1.92,
0.64
3 11592 reference -0.55 -1.78,
0.68
-0.66 -1.94,
0.62
4 11592 reference -0.51 -1.73,
0.72
-0.68 -1.95,
0.60
Diastolic blood
pressure (mm Hg)
1 11595 reference -0.63 -1.35,
0.09
-0.61 -1.35,
0.14
0.04 0.18 0.77
2 11595 reference -0.65 -1.37,
0.08
-0.63 -1.38,
0.13
3 11595 reference -0.64 -1.36,
0.09
-0.69 -1.44,
0.07
4 11595 reference -0.69 -1.42,
0.03
-0.82 -1.57,
-0.07
HDL-cholesterol
(mmol/L)
1 11526 reference -0.02 -0.03,
-0.004
-0.01 -0.03,
0.004
0.07 0.51 0.25
2 11526 reference -0.02 -0.03,
-0.004
-0.01 -0.03,
0.004
3 11526 reference -0.02 -0.03,
-0.004
-0.01 -0.02,
0.005
4 11526 reference -0.02 -0.03,
-0.004
-0.01 -0.02,
0.01
LDL-cholesterol
(mmol/L)
1 11519 reference 0.004 -0.03,
0.04
-0.02 -0.05,
0.01
0.54 0.12 0.29
2 11519 reference 0.01 -0.02,
0.04
-0.01 -0.05,
0.02
3 11519 reference 0.01 -0.02,
0.04
-0.01 -0.05,
0.02
4 11519 reference 0.01 -0.02,
0.04
-0.02 -0.05,
0.02
(Continued)
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We were unable to measure the changes of nut consumption over time, thus it is possible
that the associations of nut consumption with cardiovascular risk factors were unobserved if
the effect of nut consumption is short-term. The relatively small proportion of large amounts
of nut consumption in our population might make it difficult to observe the effect of nuts on
cardiovascular risk if high nut consumption is necessary. However, there is no reason to think
that nut consumption above a certain threshold is necessary before benefits occur and our
large sample makes it possible to detect relatively small effects even within a small range of nut
consumption.
Finally, we cannot rule out the possibility that our population were eating the wrong sort of
nuts. Peanuts were the type of nuts most commonly consumed, and peanuts are members of
the legume family as distinct from tree nuts, such as almonds, walnuts and cashew nuts. Both
legumes and tree nuts are part of a healthy diet, although the evidence from RCTs for tree nuts
and peanuts is limited and somewhat inconsistent [10, 35], Nevertheless, the benefits of nuts
could be restricted to tree nuts.
The strengths of our study included the prospective design, a large sample from an under-
studied population, whose lifetime experiences were typical of much of the global population
from middle and low income countries. Nevertheless, some limitations exist. First, our partici-
pants were not a randomly selected, representative sample. However, sample selection should
not affect internal associations, unless we missed people with specific combinations of nut con-
sumption and CVD risk. Moreover, when we used inverse probability weighting (IPW) to
account for the difference between the original sample and the sample who returned for fol-
low-up, the results were similar (data not shown). Second, we used a single measure of recalled
nut consumption. Any non-differential misclassification would likely underestimate the true
effects. Systematic recall bias by CVD risk factors is unlikely as participants were unaware of
this hypothesis at the time of interview. Third, we were unable to check the influence of nut
preparation (e.g., salted, spiced, roasted, or raw) on cardiovascular risk as we lacked data on
how nuts were prepared. Finally, we considered the change in CVD risk between baseline and
follow-up on the basis that nut consumption at baseline should change risk. However, if
Table 2. (Continued)
bModel n Nut consumption (25g portions/week) P-value
for
trend
P-value for
interaction by
sex
P-value for
interaction by
health status0
(n = 6688)
<3 (n = 2596) 3 (n = 2444)
ccoefﬁcient 95% CI coefﬁcient 95% CI
Fasting plasma
glucose (mmol/L)
1 11685 reference 0.03 -0.02,
0.08
0.04 -0.02,
0.09
0.11 0.36 0.54
2 11685 reference 0.03 -0.02,
0.09
0.04 -0.01,
0.09
3 11685 reference 0.03 -0.02,
0.09
0.04 -0.02,
0.09
4 11685 reference 0.04 -0.02,
0.09
0.04 -0.02,
0.09
aMultivariable linear regression was used for Framingham risk score; multivariable censored linear regression was used for blood pressure, cholesterol
and glucose.
bModel 1 adjusted for same factor at baseline, age, sex, daily energy intake and phase; Model 2 additionally adjusted for SEP (education, father’s
occupation, longest-held occupation and personal income) and lifestyle (smoking status, alcohol use and physical activity); Model 3 additionally adjusted
for baseline health status: Model 4 additionally adjusted for body mass index and waist-hip ratio.
cCoefﬁcient means changes in risk score; bold values indicate P<0.05.
doi:10.1371/journal.pone.0137178.t002
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Table 3. Adjusted Associations of Nut Consumption with FraminghamRisk Score and CVDRisk Factors after Multiple Imputation in Older Chinese
Men in Phases 1 and 2 of the Guangzhou Biobank Cohort Study.
bModel n Nut consumption (25g portions/week) P-value
for
trend
P-value for
interaction by
health status
P-value for
interaction
bysmoking status0
(n = 1952)
<3 (n = 653) 3 (n = 724)
ccoefﬁcient 95% CI coefﬁcient 95%
CI
aFramingham Risk
Score
1 3262 reference -0.08 -0.25,
0.09
0.05 -0.12,
0.22
0.48 0.38 0.65
2 3262 reference -0.05 -0.22,
0.12
0.08 -0.08,
0.25
3 3262 reference -0.05 -0.22,
0.13
0.08 -0.09,
0.25
4 3262 reference -0.06 -0.23,
0.11
0.06 -0.10,
0.23
Systolic blood
pressure (mm Hg)
1 3282 reference -1.76 -4.33,
0.82
-0.16 -2.70,
2.37
0.47 0.38 0.99
2 3282 reference -2.16 -4.76,
0.43
-0.52 -3.08,
2.05
3 3282 reference -1.97 -4.56,
0.62
-0.54 -3.10,
2.02
4 3282 reference -2.07 -4.64,
0.51
-0.68 -3.23,
1.88
Diastolic blood
pressure (mm Hg)
1 3284 reference -1.75 -3.59,
0.09
-0.77 -2.59,
1.04
0.13 0.37 0.79
2 3284 reference -1.94 -3.80,
-0.08
-0.99 -2.83,
0.86
3 3284 reference -1.83 -3.69,
0.03
-1.09 -2.93,
0.76
4 3284 reference -1.89 -3.75,
-0.03
-1.27 -3.11,
0.58
HDL-cholesterol
(mmol/L)
1 3276 reference -0.001 -0.03,
0.03
-0.01 -0.04,
0.01
0.37 0.56 0.71
2 3276 reference -0.01 -0.03,
0.02
-0.01 -0.04,
0.01
3 3276 reference -0.01 -0.03,
0.02
-0.01 -0.04,
0.01
4 3276 reference -0.001 -0.03,
0.02
-0.01 -0.03,
0.02
LDL-cholesterol
(mmol/L)
1 3274 reference -0.05 -0.11,
0.02
-0.01 -0.07,
0.05
0.81 0.79 0.66
2 3274 reference -0.04 -0.10,
0.02
0.002 -0.06,
0.06
3 3274 reference -0.04 -0.10,
0.02
0.002 -0.06,
0.06
4 3274 reference -0.04 -0.10,
0.02
0.003 -0.06,
0.06
(Continued)
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baseline nut consumption represents lifelong habits it might be better to examine the associa-
tion of baseline nut consumption with subsequent CVD risk. The association of baseline nut
consumption with Framingham score and its components were similarly null, except nut con-
sumption was positively associated with glucose (Tables C and D in S1 File). However, people
who consumed nuts more than 3 portions/week had fasting glucose 0.2 mmol/L higher than
people who never consumed nuts on average. Small effect sizes are meaningful at a population
level, however an effect size of 0.2 would only represent a very small change in fasting glucose.
It is increasingly apparent that associations between dietary items and cardiovascular dis-
ease observed in western settings may reflect correlation rather than causation. Specifically
some of the nutrients in nuts, such as unsaturated fats, vitamin E and magnesium have had
potentially protective observations with various aspects of cardiovascular health or overall
health refuted by RCTs [15, 36, 37]. Thus it is quite plausible that peanuts and/or tree nuts also
have no relation with cardiovascular disease, which is only evident in a setting, such as ours,
with a different pattern of confounding. In addition, salt may be introduced during the process-
ing of nuts, which might counteract any small benefits of nuts [38].
From a public health perspective, the difficulties of identifying a healthy diet from observed
associations are becoming increasingly obvious, consistent with the lack of association of nut
consumption with CVD risk in a different setting. Dietary recommendations may need to be
based on experimental evidence and should strike a balance between the potential benefits and
harms of a certain food, or food pattern.
Conclusion
Our study is not consistent with western findings that nut consumption can protect against
CVD or its risk factors. As with all observational studies these findings should be interpreted
cautiously. Given the multi-factorial etiology of CVD, investigation of the underlying factors
driving potential health benefits or harms of nuts might facilitate identification of a healthy
diet for testing.
Table 3. (Continued)
bModel n Nut consumption (25g portions/week) P-value
for
trend
P-value for
interaction by
health status
P-value for
interaction
bysmoking status0
(n = 1952)
<3 (n = 653) 3 (n = 724)
ccoefﬁcient 95% CI coefﬁcient 95%
CI
Fasting plasma
glucose (mmol/L)
1 3316 reference -0.03 -0.13,
0.07
0.05 -0.05,
0.15
0.47 0.74 0.07
2 3316 reference -0.03 -0.13,
0.07
0.03 -0.05,
0.15
3 3316 reference -0.02 -0.12,
0.08
0.05 -0.05,
0.14
4 3316 reference -0.03 -0.13,
0.07
0.04 -0.05,
0.14
aMultivariable linear regression was used for Framingham risk score; multivariable censored linear regression was used for blood pressure, cholesterol
and glucose.
bModel 1 adjusted for same factor at baseline, age, daily energy intake and phase; Model 2 additionally adjusted for SEP (education, father’s occupation,
longest-held occupation and personal income) and lifestyle (smoking status, alcohol use and physical activity); Model 3 additionally adjusted for baseline
health status: Model 4 additionally adjusted for body mass index and waist-hip ratio.
doi:10.1371/journal.pone.0137178.t003
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